World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
110
Citations
40447
World Ranking
509
National Ranking
308

Medicine

D-Index
110
Citations
40520
World Ranking
5606
National Ranking
3014

Overview

Steven G. Reed is affiliated with the Infectious Disease Research Institute in the United States. Their research activities span multiple fields within medicine, notably focusing on immunology and microbiology. The subfields in which they are active include immunology, infectious diseases, public health, environmental and occupational health, epidemiology, and molecular biology.

The main topics covered by their research include immunotherapy and immune responses, research on leishmaniasis studies, Trypanosoma species research and implications, immune cell function and interaction, SARS-CoV-2 and COVID-19 research, tuberculosis research and epidemiology, and the immune response and inflammation.

Steven G. Reed has contributed to several recent papers, including:

  • New horizons in adjuvants for vaccine development (2020, Current Opinion in Immunology)
  • An Alphavirus-derived replicon RNA vaccine induces SARS-CoV-2 neutralizing antibody and T cell responses in mice and nonhuman primates (2020, Science Translational Medicine)
  • 3M-052, a synthetic TLR-7/8 agonist, induces durable HIV-1 envelope-specific plasma cells and humoral immunity in nonhuman primates (2020, Science Immunology)
  • Intramuscular Delivery of Replicon RNA Encoding ZIKV-117 Human Monoclonal Antibody Protects against Zika Virus Infection (2020, Molecular Therapy - Methods & Clinical Development)
  • Safety and immunogenicity of the adjunct therapeutic vaccine ID93 + GLA-SE in adults who have completed treatment for tuberculosis: a randomised, double-blind, placebo-controlled, phase 2a trial (2020, The Lancet Respiratory Medicine)

The scientist collaborates frequently with several coauthors who have appeared alongside them in multiple publications. These include:

  • Amit P. Khandhar
  • Malcolm S. Duthie
  • Rhea N. Coler
  • Jesse H. Erasmus
  • Jacob Archer

Steven G. Reed has published several papers in common venues, with a concentration in the following journals:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Vaccines
  • PLoS ONE
  • Cell Reports
  • Current Opinion in Immunology

Best Publications

  • Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major.

    Patricia A Darrah;Dipti T Patel;Paula M De Luca;Ross W B Lindsay

  • Key roles of adjuvants in modern vaccines

    Steven G Reed;Mark T Orr;Christopher B Fox

  • New horizons in adjuvants for vaccine development

    Steven G. Reed;Sylvie Bertholet;Rhea N. Coler;Martin Friede

  • Identification of differentially expressed genes in human prostate cancer using subtraction and microarray.

    Jiangchun Xu;John A. Stolk;Xinqun Zhang;Sandra J. Silva

  • New Perspectives on a Subclinical Form of Visceral Leishmaniasis

    R. Badaro;T. C. Jones;E. M. Carvalho;D. Sampaio

  • P504S: a new molecular marker for the detection of prostate carcinoma.

    Zhong Jiang;Bruce A. Woda;Kenneth L. Rock;Yingdan Xu

  • Interleukin 10 production correlates with pathology in human Leishmania donovani infections.

    H. W. Ghalib;M. R. Piuvezam;Y. A.W. Skeiky;M. Siddig

  • Use of defined TLR ligands as adjuvants within human vaccines.

    Malcolm S. Duthie;Hillarie Plessner Windish;Christopher B. Fox;Steven G. Reed

  • CD40 Ligand Is Required for Protective Cell-Mediated Immunity to Leishmania major

    Kim A Campbell;Pamela J Ovendale;Mary K Kennedy;William C Fanslow

  • Differential immune responses and protective efficacy induced by components of a tuberculosis polyprotein vaccine, Mtb72F, delivered as naked DNA or recombinant protein.

    Yasir A. W. Skeiky;Mark R. Alderson;Pamela J. Ovendale;Jeffrey A. Guderian

  • Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis.

    Edgar M. Carvalho;Roberto Badaro;Steven G. Reed;Thomas C. Jones

  • rK39: A Cloned Antigen of Leishmania chagasi that Predicts Active Visceral Leishmaniasis

    R. Badaró;D. Benson;M. C. Eulálio;M. Freire

  • Taking toll: lipid A mimetics as adjuvants and immunomodulators.

    David H Persing;Rhea N Coler;Michael J Lacy;David A Johnson

  • Development and characterization of synthetic glucopyranosyl lipid adjuvant system as a vaccine adjuvant.

    Rhea N. Coler;Sylvie Bertholet;Magdalini Moutaftsi;Jeff A. Guderian

  • Second-generation vaccines against leishmaniasis

    Rhea N. Coler;Steven G. Reed

  • Rapid accurate field diagnosis of Indian visceral leishmaniasis

    Shyam Sundar;Steven G. Reed;Vijay P. Singh;Prasanna C. K. Kumar

  • Reducing the global burden of tuberculosis: the contribution of improved diagnostics

    Emmett Keeler;Mark D. Perkins;Peter Small;Christy Hanson

  • A Defined Tuberculosis Vaccine Candidate Boosts BCG and Protects Against Multidrug Resistant Mycobacterium tuberculosis

    Sylvie Bertholet;Gregory C. Ireton;Diane J. Ordway;Hillarie Plessner Windish

  • Epidemiology of American Cutaneous Leishmaniasis Due to Leishmania braziliensis braziliensis

    Jones Tc;Johnson Wd;Barretto Ac;Lago E

  • Adjuvants for cancer vaccines.

    Thomas W. Dubensky;Steven G. Reed

Frequent Co-Authors

Rhea N. Coler
Rhea N. Coler University of Washington
Yasir A. W. Skeiky
Yasir A. W. Skeiky International AIDS Vaccine Initiative
Roberto Badaró
Roberto Badaró Federal University of Bahia
Mark R. Alderson
Mark R. Alderson Program for Appropriate Technology in Health
Ian M. Orme
Ian M. Orme Colorado State University
David C. Montefiori
David C. Montefiori Duke University
Barton F. Haynes
Barton F. Haynes Duke University
Georgia D. Tomaras
Georgia D. Tomaras Duke University
Shyam Sundar
Shyam Sundar Banaras Hindu University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, pursuing related healthcare degrees can open diverse career opportunities. Nursing remains a popular and accessible pathway, especially through 12-month accelerated nursing programs that allow for fast-tracked entry into the profession.

If you're seeking foundational nursing credentials, exploring lpn programs with easiest admission requirements can be a smart move. These programs typically have less stringent entry criteria, making them ideal for those new to the field.

For advanced practice roles, nurse practitioner programs with easy admission offer a streamlined path to expand clinical knowledge and qualify for more specialized positions.

Specializing in mental health is another growing area, and top psychiatric mental health nurse practitioner programs online provide excellent training along with strong clinical placement support, crucial for hands-on experience.

These related degrees complement immunology studies by enhancing practical skills and increasing employability across healthcare sectors.

Best Scientists Citing Steven G. Reed

Trending Scientists

Recently Published Articles